Cargando…

Primary Central Nervous System Anaplastic Large T-cell Lymphoma

INTRODUCTION: Primary central nervous system lymphoma (PCNSL) of T-cell origin is an exceptionally rare, highly malignant intracranial neoplasm. Although such a tumor typically presents with a focal mass lesion. CASE REPORT: Past medical history of a 26-year-old male patient with a PCNS lymphoma of...

Descripción completa

Detalles Bibliográficos
Autores principales: Splavski, Bruno, Muzevic, Dario, Ladenhauser-Palijan, Tatjana, Jr, Brano Splavski
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034991/
https://www.ncbi.nlm.nih.gov/pubmed/27703297
http://dx.doi.org/10.5455/medarh.2016.70.311-313
_version_ 1782455359136333824
author Splavski, Bruno
Muzevic, Dario
Ladenhauser-Palijan, Tatjana
Jr, Brano Splavski
author_facet Splavski, Bruno
Muzevic, Dario
Ladenhauser-Palijan, Tatjana
Jr, Brano Splavski
author_sort Splavski, Bruno
collection PubMed
description INTRODUCTION: Primary central nervous system lymphoma (PCNSL) of T-cell origin is an exceptionally rare, highly malignant intracranial neoplasm. Although such a tumor typically presents with a focal mass lesion. CASE REPORT: Past medical history of a 26-year-old male patient with a PCNS lymphoma of T-cell origin was not suggestive of intracranial pathology or any disorder of other organs and organic systems. To achieve a gross total tumor resection, surgery was performed via osteoplastic craniotomy using the left frontal transcortical transventricular approach. Histological and immunohistochemical analyses of the tissue removed described tumor as anaplastic large cell lymphoma of T-cells (T-ALCL). Postoperative and neurological recovery was complete, while control imaging of the brain showed no signs of residual tumor at a six-month follow-up. The patient, who did not appear immunocompromized, was referred to a hematologist and an oncologist where corticosteroids, the particular chemotherapeutic protocol and irradiation therapy were applied. CONCLUSION: Since PCNS lymphoma is a potentially curable brain tumor, we believe that proper selection of the management options, including early radical tumor resection for solitary PCNS lymphoma, may be proposed as a major treatment of such a tumor in selected patients, resulting in a satisfactory outcome.
format Online
Article
Text
id pubmed-5034991
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AVICENA, d.o.o., Sarajevo
record_format MEDLINE/PubMed
spelling pubmed-50349912016-10-04 Primary Central Nervous System Anaplastic Large T-cell Lymphoma Splavski, Bruno Muzevic, Dario Ladenhauser-Palijan, Tatjana Jr, Brano Splavski Med Arch Case Report INTRODUCTION: Primary central nervous system lymphoma (PCNSL) of T-cell origin is an exceptionally rare, highly malignant intracranial neoplasm. Although such a tumor typically presents with a focal mass lesion. CASE REPORT: Past medical history of a 26-year-old male patient with a PCNS lymphoma of T-cell origin was not suggestive of intracranial pathology or any disorder of other organs and organic systems. To achieve a gross total tumor resection, surgery was performed via osteoplastic craniotomy using the left frontal transcortical transventricular approach. Histological and immunohistochemical analyses of the tissue removed described tumor as anaplastic large cell lymphoma of T-cells (T-ALCL). Postoperative and neurological recovery was complete, while control imaging of the brain showed no signs of residual tumor at a six-month follow-up. The patient, who did not appear immunocompromized, was referred to a hematologist and an oncologist where corticosteroids, the particular chemotherapeutic protocol and irradiation therapy were applied. CONCLUSION: Since PCNS lymphoma is a potentially curable brain tumor, we believe that proper selection of the management options, including early radical tumor resection for solitary PCNS lymphoma, may be proposed as a major treatment of such a tumor in selected patients, resulting in a satisfactory outcome. AVICENA, d.o.o., Sarajevo 2016-07-27 2016-08 /pmc/articles/PMC5034991/ /pubmed/27703297 http://dx.doi.org/10.5455/medarh.2016.70.311-313 Text en Copyright: © 2016 Bruno Splavski, Dario Muzevic, Tatjana Ladenhauser-Palijan, and Brano Splavski Jr http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Splavski, Bruno
Muzevic, Dario
Ladenhauser-Palijan, Tatjana
Jr, Brano Splavski
Primary Central Nervous System Anaplastic Large T-cell Lymphoma
title Primary Central Nervous System Anaplastic Large T-cell Lymphoma
title_full Primary Central Nervous System Anaplastic Large T-cell Lymphoma
title_fullStr Primary Central Nervous System Anaplastic Large T-cell Lymphoma
title_full_unstemmed Primary Central Nervous System Anaplastic Large T-cell Lymphoma
title_short Primary Central Nervous System Anaplastic Large T-cell Lymphoma
title_sort primary central nervous system anaplastic large t-cell lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034991/
https://www.ncbi.nlm.nih.gov/pubmed/27703297
http://dx.doi.org/10.5455/medarh.2016.70.311-313
work_keys_str_mv AT splavskibruno primarycentralnervoussystemanaplasticlargetcelllymphoma
AT muzevicdario primarycentralnervoussystemanaplasticlargetcelllymphoma
AT ladenhauserpalijantatjana primarycentralnervoussystemanaplasticlargetcelllymphoma
AT jrbranosplavski primarycentralnervoussystemanaplasticlargetcelllymphoma